| Application no. and date | 10009414.3 (espacenet) (Federated) (European Patent Register), 20040312 | | Patent/reg. no. and date | DK/EP 2275413, 20130306 | | Publication date | 20110119 | | Priority no. and date | GB 0305929, 20030314, GB 0319227, 20030815, GB 0322370, 20030924 | | EP pub. no. and date |
EP 2275413 20110119 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 157351 | | Inventor | OHMORI, Osamu, 685-1-B4 Mifuku
Izunokuni-shi
Shizuoka 410-2321, JP,
GARCIA-ECHEVERRIA, Carlos, Engelgasse 126
4052 Basel, CH,
Kawahara, Eiji, 4-20, Inarimae
Tsukuba-shi
Ibaraki Pref. 305-0061, JP,
Kanazawa, Takanori, c/o Novartis Pharma K.K., Oncology B.U.
Kowa Nishi-Azabu Bldg. 1, 6F
4-12-24 Nishi-Azabu
Minato-ku
Tokyo 106-0031, JP,
Miyake, Takahiro, Grand Seed Emile Room 102
2-9-8 Kumochi-chou, Chuo-ku
Kobe-shi
Hyogo 651-0056, JP,
Umemura, Ichiro, Park Hill Azuma 1-401
3-19-1 Azuma
Tsukuba-shi
Ibaraki 305-0031, JP,
Masuya, Keiichi, c/o Novartis Pharma AG
Werk Klybeck
Postfach
4002 Basel, CH,
Matsuura, Naoko, c/o Novartis Pharma K.K.
4-17-30, Nishi-Azabu
Minato-ku
Tokyo 106-8618, JP | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 35/00 (2006.01) , A61P 29/00 (2006.01) , A61P 37/00 (2006.01) , C07D 239/48 (2006.01) , C07D 401/12 (2006.01) , C07D 401/14 (2006.01) , C07D 403/12 (2006.01) , C07D 405/12 (2006.01) , C07D 405/14 (2006.01) | | Title | 2,4-di(phenylamino)-pyrimidiner egnede til behandlingen af neoplastiske sygdomme, inflammatoriske og immunsystem lidelser. | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
